Current and future use of remdesivir in patients with COVID-19

Abstract

There are prerequisites for the use of remdesivir against SARS-CoV-2 in stationary conditions. Remdesivir is not registered in the Russian Federation. The preliminary results of randomized clinical trials on the efficacy of remission are contradictory.

Keywords

• коронавирус
• ремдесивир
• covid-19